0001213900-21-047758.txt : 20210913
0001213900-21-047758.hdr.sgml : 20210913
20210913181747
ACCESSION NUMBER: 0001213900-21-047758
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210909
FILED AS OF DATE: 20210913
DATE AS OF CHANGE: 20210913
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Robin L
CENTRAL INDEX KEY: 0001365035
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38914
FILM NUMBER: 211250704
MAIL ADDRESS:
STREET 1: C/O PHASE III MEDICAL, INC.
STREET 2: 330 SOUTH SERVICE ROAD, SUITE 120
CITY: MELVILLE
STATE: NY
ZIP: 11747
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celularity Inc
CENTRAL INDEX KEY: 0001752828
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831702591
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1325 AVENUE OF THE AMERICAS
STREET 2: 25TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 2126163700
MAIL ADDRESS:
STREET 1: 1325 AVENUE OF THE AMERICAS
STREET 2: 25TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER COMPANY:
FORMER CONFORMED NAME: GX Acquisition Corp.
DATE OF NAME CHANGE: 20180912
4
1
ownership.xml
X0306
4
2021-09-09
0
0001752828
Celularity Inc
CELU
0001365035
Smith Robin L
C/O CELULARITY INC.
170 PARK AVENUE
FLORHAM PARK
NJ
07932
1
0
0
0
Stock Option (Right to Buy)
6.72
2021-09-09
4
A
0
56053
0.00
A
2031-09-09
Class A Common Stock
56053
56053
D
This option shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant, September 9, 2021, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through each such date.
/s/ Keary Dunn, Attorney-in-Fact
2021-09-13